It’s business as usual for Big Pharma.
After a brief stoppage of the J&J COVID-19 jab, an independent advisory panel for the CDC voted for it to resume on the FDA’s emergency use authorization.
So, the drug is still not FDA approved and there are known life-threatening risk factors.
No thanks, I’ll pass on that experimental cocktail.
The CDC and FDA lifted the pause on Johnson & Johnson’s COVID-19 vaccine Friday night.
But unlike Pfizer and Moderna’s shots, J&J’s single-dose vaccine will likely come with a warning about the potential risk of rare blood clots.@NikkiBattiste has more https://t.co/lAN3wGgJNa pic.twitter.com/vidPSRANmT
— CBS Evening News (@CBSEveningNews) April 24, 2021
— Meg Tirrell (@megtirrell) April 23, 2021
Breaking News: The FDA ended its recommended pause on the Johnson & Johnson vaccine, clearing the way for states across